Fibromyalgia in Rheumatiod and Psoriatic Patients

the study based on investigate for fibromyalgia among rheumatiod arthritis patient and psoriatic arthritis.....and to what extent gibromyalgia affect disease activity indices ....and its relation to serum Vitamin D level in those patients

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Fibromyalgia, Secondary Fibromyalgia Muscular Diseases Musculoskeletal Diseases Nervous System Diseases Neuromuscular Diseases Rheumatic Diseases

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Sohag University Hospital

Sohag, Egypt

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

adult onset disease any patient diagnosed as rheumatiod arthritis and psoriatic arthritis above18years old

Exclusion criteria

any other autoimmune diseases

Treatment and study plan

Serum vitaminDlevel

Diagnostic Test

Investigate about fibromyalgia in psoiaritic and rheumatiod arthritis patients ...and assesment of seum vitamin D level

Primary outcomes

Serum vitamin D level

Time frame: One year

Blood test to asses hypovitaminosis in these patients

Sponsors and collaborators

Lead sponsor

Sohag University

Other

Registry information

Official study title

Fibromyalgia in Rheumatiod and Psoriatic Arthritis Patients:Relationshipwith Disease Activity and Serum Vitamin Dlevel

Important dates

Study start: 2021
Primary completion: 2022
Study completion: 2022
First posted: May 19, 2021
Registry last updated: Apr 7, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed